IFNγ PET imaging as a predictive tool for monitoring response to tumor immunotherapy HM Gibson, BN McKnight, A Malysa, G Dyson, WN Wiesend, ... Cancer research 78 (19), 5706-5717, 2018 | 91 | 2018 |
The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53 C Hu, M Zhang, N Moses, C Hu, L Polin, W Chen, H Jang, J Heyza, ... Cell death & disease 11 (5), 328, 2020 | 47 | 2020 |
USP10 regulates Musashi‐2 stability via deubiquitination and promotes tumour proliferation in colon cancer S Ouyang, T Liu, X Liu, F Zhu, F Zhu, X Liu, Z Peng FEBS letters 593 (4), 406-413, 2019 | 39 | 2019 |
Choline phosphate cytidylyltransferase‐α is a novel antigen detected by the anti‐ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell … AE Vaezi, G Bepler, NR Bhagwat, A Malysa, JM Rubatt, W Chen, BL Hood, ... Cancer 120 (12), 1898-1907, 2014 | 37 | 2014 |
The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer M Al Sorkhy, RM Ferraiuolo, E Jalili, A Malysa, AR Fratiloiu, BF Sloane, ... BMC cancer 12, 1-14, 2012 | 32 | 2012 |
A kinome screen identifies checkpoint kinase 1 (CHK1) as a sensitizer for RRM1-dependent gemcitabine efficacy J Zhou, Z Chen, A Malysa, X Li, P Oliveira, Y Zhang, G Bepler PloS one 8 (3), e58091, 2013 | 29 | 2013 |
RUMI is a novel negative prognostic marker and therapeutic target in non–small‐cell lung cancer M Chammaa, A Malysa, C Redondo, H Jang, W Chen, G Bepler, ... Journal of cellular physiology 233 (12), 9548-9562, 2018 | 15 | 2018 |
Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor … A Wallace-Povirk, L Rubinsak, A Malysa, SH Dzinic, M Ravindra, ... Scientific reports 12 (1), 11346, 2022 | 12 | 2022 |
Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over … M Patki, T McFall, R Rosati, Y Huang, A Malysa, L Polin, A Fielder, ... Scientific Reports 8 (1), 16006, 2018 | 10 | 2018 |
The mechanisms of zinc action as a potent anti-viral agent: the clinical therapeutic implication in COVID-19 AS Prasad, A Malysa, G Bepler, A Fribley, B Bao Antioxidants 11 (10), 1862, 2022 | 7 | 2022 |
Frequency of anaplastic lymphoma kinase (ALK) positive tumors among African American non-small cell lung cancer (NSCLC) patients. SM Gadgeel, ML Cote, G Bepler, V Murphy, A Malysa, AJ Wozniak, ... Journal of Clinical Oncology 30 (15_suppl), 7593-7593, 2012 | 4 | 2012 |
Discoidin Domain Receptors in Health and Disease R Fridman, PH Huang Springer, 2016 | 1 | 2016 |
CCTα is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in lung and head and neck squamous cell carcinomas A Vaezi, G Bepler, N Bhagwat, A Malysa, J Rubatt, W Chen, B Hood, ... Cancer 120 (12), 1898, 2014 | 1 | 2014 |
The Role of Spy1 in Mammary Morphogenesis A Malysa University of Windsor, 2011 | 1 | 2011 |
Host genetic background affects response to immune checkpoint inhibitors in a B16 melanoma model using Diversity Outbred mice J Hackett, C McCarthy, M Muniz, A Malysa, W Wiesend, H Gibson The Journal of Immunology 202 (1_Supplement), 195.30-195.30, 2019 | | 2019 |
Cover Image, Volume 233, Number 12, December 2018 M Chammaa, A Malysa, C Redondo, H Jang, W Chen, G Bepler, ... Journal of Cellular Physiology 233 (12), i-i, 2018 | | 2018 |
Discoidin Domain Receptors in Lung Cancer Y Zhang, A Malysa, G Bepler Discoidin Domain Receptors in Health and Disease, 145-154, 2016 | | 2016 |